Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus

We describe a treatment made with interferon-alpha (IFN-alpha) plus ribavirin of two patients with membranoproliferative glomerulonephritis (MPGN) induced by hepatitis C virus (HCV): Case 1 was a 22-year-old woman with leg and facial edema, hypertension and proteinuria, whose liver biopsy revealed c...

Full description

Bibliographic Details
Main Authors:	Edmundo P.A. Lopes, Lucila M. Valente, A. Eduardo B. Silva, Gianna Mastroianni Kirsztajn, Cibele N. Cruz, Maria Lucia G Ferraz
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Glomerulonephritis hepatitis C interferon ribavirin
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500011&lng=en&tlng=en

Similar Items

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)

<FONT FACE=Symbol>a</FONT>-Interferon therapy for HBV-related glomerulonephritis
by: Edmundo Pessoa de Almeida Lopes Neto, et al.

Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney outcomes
by: Thaíza Passaglia Bernardes, et al.
Published: (2022-06-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, et al.

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
by: Luis Jesuíno de Oliveira Andrade, et al.

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.
by: Mansour Hassan, et al.
Published: (2020-01-01)

Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
by: Hamid Kalantari, et al.
Published: (2007-08-01)

Cryoglobulinemic glomerulonephritis: an extrahepatic manifestation of hepatitis C virus (HCV) infection
by: Giovanni Garini, et al.
Published: (2007-12-01)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, et al.

Ocular manifestations in Egyptian children with chronic hepatitis C treated with pegylated interferon and ribavirin
by: Dalia H.A.R Khalil, et al.
Published: (2016-01-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease?
by: M Wilhelmi, et al.
Published: (2006-01-01)

Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC)
by: Gupta Rahul, et al.
Published: (2012-03-01)

ORIGINAL PAPER <br>Combined interferon-alpha-2b and ribavirin therapy in patients with recurring chronic hepatitis C (genotype 1) following liver transplantation in Hungary
by: Gabriella Lengyel, et al.
Published: (2005-04-01)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection
by: Hussien Ahmed, et al.
Published: (2017-03-01)

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
by: Yin-Qiu Huang, et al.
Published: (2020-07-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.
by: Adnan Agha
Published: (2014-08-01)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
by: Nishikawa Hiroki, et al.
Published: (2012-03-01)

Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
by: Luisa Cavalletto, et al.
Published: (2008-01-01)

Evaluation of combination therapy with Interferon and Ribavirin in patients with chronic hepatitis C : a genotype based study
by: Y. Bafandeh, et al.
Published: (2007-01-01)

Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
by: Shin-Yu Lu, et al.
Published: (2009-12-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection
by: Delić Dragan, et al.
Published: (2012-01-01)

Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting
by: Sergio Sabbatani, et al.

Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
by: M.H.P. Pavan, et al.

Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis
by: Edison Roberto Parise, et al.

Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan
by: Jung-An Lin, et al.
Published: (2014-10-01)

Interferon alpha-2b and ribavirin as combined therapy for chronic hepatitis C in Cuba: National Program
by: Hugo Nodarse-Cuní, et al.

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon® plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients
by: Marlen I Castellanos-Fernández, et al.

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine
by: Yanet Parodis López, et al.
Published: (2005-08-01)

Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
by: Kleber Prado, et al.

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
by: Ta-Wei Liu, et al.
Published: (2018-01-01)

Tratamento de pacientes com hepatite crônica pelo vírus C com interferon-alfa e ribavirina: a experiência da Secretaria de Saúde do Rio Grande do Sul Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil
by: Alexandro Vaesken Alves, et al.
Published: (2003-12-01)

Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)